Several genes strongly related to pyruvate metabolism, glycolysis/gluconeogenesis, and tyrosine metabolism, including ACSS2, were found to be significantly downregulated in PGG-treated MDA-MB-231 breast cancer cells. Here, ACSS2 is linked to breast carcinoma.